Literature DB >> 16288672

Stability of the Bayley II Scales of Infant Development in a sample of low-risk and high-risk infants.

Susan R Harris1, Antoinette M Megens, Catherine L Backman, Virginia E Hayes.   

Abstract

The aim of this study was to examine the stability of the second edition of the Bayley Scales of Infant Development (Bayley II) by correlating Bayley II scores during the first year of life with Bayley II scores at approximately 18 months of age. Bayley II Mental and Motor Scales were administered to 119 infants (69 males, 50 females) during their first year of life; mean age for low-risk group 7 months (SD 3.01) and mean age for high-risk group 7.8 months (SD 2.46). A second set of Bayley II scores was collected on 104 of the infants at 17 to 22 months of age; mean age for low-risk group 18.5 months (SD 1.07) and mean age for high-risk group 18.9 months (SD 1.11). Mean time interval between the two assessments was 11.5 months for the low-risk group and 11.15 months for the high-risk group. Stability of the scores over time was assessed. Correlations for the Bayley II Mental Developmental Index and Psychomotor Developmental Index between administrations during the first and second years of life were r=0.49 (p<0.001) and r=0.48 (p<0.001) respectively. We conclude that approximately 23 to 24% of the variance in the infants' later Bayley II scores could be explained by the earlier scores. This is one of only two studies to examine the stability of Bayley II over time. Replication studies are needed to evaluate the consistency of these findings across other samples of infants.

Entities:  

Mesh:

Year:  2005        PMID: 16288672     DOI: 10.1017/S0012162205001738

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  16 in total

1.  Early developmental outcomes of children with congenital HHV-6 infection.

Authors:  Mary T Caserta; Caroline B Hall; Richard L Canfield; Philip Davidson; Gerry Lofthus; Kenneth Schnabel; Jennifer Carnahan; Lynne Shelley; Hongyue Wang
Journal:  Pediatrics       Date:  2014-11-03       Impact factor: 7.124

2.  Current status of neonatal follow-up in Canada.

Authors:  Anne R Synnes; Francine Lefebvre; Heather A Cake
Journal:  Paediatr Child Health       Date:  2006-05       Impact factor: 2.253

3.  Trajectories of cognitive development among American Indian young children.

Authors:  Christina M Mitchell; Calvin Croy; Paul Spicer; Karen Frankel; Robert N Emde
Journal:  Dev Psychol       Date:  2011-07

4.  White Matter Volume Predicts Language Development in Congenital Heart Disease.

Authors:  Caitlin K Rollins; Lisa A Asaro; Alireza Akhondi-Asl; Barry D Kussman; Michael J Rivkin; David C Bellinger; Simon K Warfield; David Wypij; Jane W Newburger; Janet S Soul
Journal:  J Pediatr       Date:  2016-11-09       Impact factor: 4.406

5.  Comparison of the developmental tests Bayley-III and Bayley-II in 7-month-old infants born preterm.

Authors:  Gitta Reuner; Anna Christine Fields; Andrea Wittke; Martin Löpprich; Joachim Pietz
Journal:  Eur J Pediatr       Date:  2012-12-08       Impact factor: 3.183

6.  Developmental scores at 1 year with increasing gestational age, 37-41 weeks.

Authors:  Olga Rose; Estela Blanco; Suzanna M Martinez; Eastern Kang Sim; Marcela Castillo; Betsy Lozoff; Yvonne E Vaucher; Sheila Gahagan
Journal:  Pediatrics       Date:  2013-04-15       Impact factor: 7.124

7.  Neurodevelopmental effects of maternal nutritional status and exposure to methylmercury from eating fish during pregnancy.

Authors:  Philip W Davidson; J J Strain; Gary J Myers; Sally W Thurston; Maxine P Bonham; Conrad F Shamlaye; Abbie Stokes-Riner; Julie M W Wallace; Paula J Robson; Emeir M Duffy; Lesley A Georger; Jean Sloane-Reeves; Elsa Cernichiari; Richard L Canfield; Christopher Cox; Li Shan Huang; Joanne Janciuras; Thomas W Clarkson
Journal:  Neurotoxicology       Date:  2008-06-11       Impact factor: 4.294

8.  Brain Injury and Development in Preterm Infants Exposed to Fentanyl.

Authors:  Christopher McPherson; Matthew Haslam; Roberta Pineda; Cynthia Rogers; Jeffrey J Neil; Terrie E Inder
Journal:  Ann Pharmacother       Date:  2015-09-14       Impact factor: 3.154

9.  Erythropoietin neuroprotection in neonatal cardiac surgery: a phase I/II safety and efficacy trial.

Authors:  Dean B Andropoulos; Ken Brady; Ronald B Easley; Heather A Dickerson; Robert G Voigt; Lara S Shekerdemian; Marcie R Meador; Carol A Eisenman; Jill V Hunter; Marie Turcich; Carlos Rivera; Emmett D McKenzie; Jeffrey S Heinle; Charles D Fraser
Journal:  J Thorac Cardiovasc Surg       Date:  2012-10-23       Impact factor: 5.209

10.  Can Alberta infant motor scale and milani comparetti motor development screening test be rapid alternatives to bayley scales of infant development-II at high-risk infants.

Authors:  Zeynep Hoşbay Yıldırım; Nur Aydınlı; Barış Ekici; Burak Tatlı; Mine Calişkan
Journal:  Ann Indian Acad Neurol       Date:  2012-07       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.